NLN, neurolysin, 57486

N. diseases: 74; N. variants: 3
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs149645408
rs149645408
Entrez Id: 57486
Gene Symbol: NLN
NLN
CUI: C0021704
Disease:
Intelligence 		0.700 GeneticVariation GWASCAT Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. 29844566 2018
dbSNP: rs2262994
rs2262994
Entrez Id: 57486
Gene Symbol: NLN
NLN
CUI: C0026654
Disease:
Moyamoya Disease 		G 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593 2018
dbSNP: rs2262994
rs2262994
Entrez Id: 57486
Gene Symbol: NLN
NLN
CUI: C2931384
Disease:
Moyamoya disease 1 		G 0.700 GeneticVariation GWASCAT Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study. 29273593 2018
dbSNP: rs199720399
rs199720399
Entrez Id: 57486
Gene Symbol: NLN
NLN
CUI: C0013595
Disease:
Eczema 		0.010 GeneticVariation BEFREE After stratifying by phthalate metabolite levels, FLG P478S TT genotype was related to a higher odds of AD in children with high MBP levels (aOR=4.74, 95% CI 1.45-15.5) and in children with high MBzP levels (aOR=3.46, 95%CI 1.03-11.58). 25460639 2015
dbSNP: rs199720399
rs199720399
Entrez Id: 57486
Gene Symbol: NLN
NLN
CUI: C0011615
Disease:
Dermatitis, Atopic 		0.010 GeneticVariation BEFREE After stratifying by phthalate metabolite levels, FLG P478S TT genotype was related to a higher odds of AD in children with high MBP levels (aOR=4.74, 95% CI 1.45-15.5) and in children with high MBzP levels (aOR=3.46, 95%CI 1.03-11.58). 25460639 2015